• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺胺甲恶唑复方制剂治疗急性单纯性尿路感染的双盲对照研究

Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.

作者信息

Skjerven O, Bergan T

出版信息

Infection. 1979;7 Suppl 4:S398-400. doi: 10.1007/BF01639020.

DOI:10.1007/BF01639020
PMID:389813
Abstract

The effects of a twice daily dosage of a combination of 410 mg sulphadiazine + 90 mg trimethoprim (SD + TMP) and 800 mg sulphamethoxazole + 160 mg trimethoprim (SMZ + TMP) were compared in uncomplicated urinary tract infections. All but one patient in each treatment group, i.e. 36 SD + TMP treated and 42 SMZ + TMP treated patients respectively, were cured. The percentage of side-effects related to therapy in the patients receiving the combination with sulphadiazine was 15.1% and in those with sulphamethoxazole 23.7%. Due to the small number tested, however, differences were not statistically different. It is noteworthy that only one of the SD + TMP patients had to stop therapy because of a rash, whereas therapy was stopped for this reason in three of the SMZ + TMP patients. SD + TMP represents a good alternative to SMZ + TMP in the treatment of urinary tract infections.

摘要

在单纯性尿路感染中,比较了每日两次服用410毫克磺胺嘧啶+90毫克甲氧苄啶(SD + TMP)和800毫克磺胺甲恶唑+160毫克甲氧苄啶(SMZ + TMP)组合的效果。每个治疗组除一名患者外,即分别有36名接受SD + TMP治疗的患者和42名接受SMZ + TMP治疗的患者均治愈。接受磺胺嘧啶组合治疗的患者中与治疗相关的副作用百分比为15.1%,接受磺胺甲恶唑治疗的患者中为23.7%。然而,由于测试数量较少,差异无统计学意义。值得注意的是,SD + TMP组中只有一名患者因皮疹不得不停止治疗,而SMZ + TMP组中有三名患者因此原因停止治疗。在尿路感染的治疗中,SD + TMP是SMZ + TMP的一个良好替代方案。

相似文献

1
Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.磺胺甲恶唑复方制剂治疗急性单纯性尿路感染的双盲对照研究
Infection. 1979;7 Suppl 4:S398-400. doi: 10.1007/BF01639020.
2
Comparison of sulphadiazine-trimethoprim and sulphamethoxazole-trimethoprim in the treatment of acute respiratory tract infections. Randomized double-blind trial.磺胺嘧啶-甲氧苄啶与磺胺甲恶唑-甲氧苄啶治疗急性呼吸道感染的比较。随机双盲试验。
Chemotherapy. 1980;26(4):297-300. doi: 10.1159/000237920.
3
A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections.复方磺胺嘧啶与复方新诺明和磺胺林治疗尿路感染的临床研究。
Infection. 1979;7 Suppl 4:S401-3. doi: 10.1007/BF01639021.
4
Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
J Infect Dis. 1987 Feb;155(2):170-7. doi: 10.1093/infdis/155.2.170.
5
Acute cystitis: a prospective study of laboratory tests and duration of therapy.急性膀胱炎:实验室检查与治疗疗程的前瞻性研究
Mayo Clin Proc. 1984 Jun;59(6):391-7. doi: 10.1016/s0025-6196(12)61461-x.
6
Treatment of urinary tract infections with sulphonamide and/or trimethoprim. A preliminary report from a multipractice study.用磺胺类药物和/或甲氧苄啶治疗尿路感染。一项多机构研究的初步报告。
Infection. 1979;7 Suppl 4:S414-5. doi: 10.1007/BF01639025.
7
Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.利福平-甲氧苄啶与磺胺甲恶唑-甲氧苄啶治疗局限性尿路感染的随机临床试验。
Antimicrob Agents Chemother. 1988 Jun;32(6):802-6. doi: 10.1128/AAC.32.6.802.
8
Rifaprim in urinary tract infection: a comparison with co-trimoxazole.
J Antimicrob Chemother. 1983 Mar;11(3):239-44. doi: 10.1093/jac/11.3.239.
9
The use of co-trimazine and co-trimoxazole in elderly patients with urinary tract infections.复方磺胺嘧啶和复方新诺明在老年尿路感染患者中的应用。
Infection. 1979;7 Suppl 4:S404-7. doi: 10.1007/BF01639022.
10
Sulfadiazine-trimethoprim combination in the treatment of urinary tract infections.磺胺嘧啶-甲氧苄啶联合用药治疗尿路感染
Chemotherapy. 1977;23(5):337-44. doi: 10.1159/000222003.

引用本文的文献

1
Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta-analysis with active comparator disproportionality analysis.磺胺甲恶唑-甲氧苄啶用于门诊治疗细菌感染的安全性:一项采用活性对照药物不均衡性分析的系统评价和荟萃分析
Br J Clin Pharmacol. 2025 Jun;91(6):1632-1648. doi: 10.1111/bcp.70051.
2
Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta-analysis with active comparator disproportionality analysis.磺胺甲恶唑-甲氧苄啶用于门诊治疗细菌感染的安全性:一项采用活性对照品不成比例分析的系统评价和荟萃分析。
Br J Clin Pharmacol. 2025 Jun;91(6):1632-1648. doi: 10.1002/bcp.70051. Epub 2025 Mar 24.
3

本文引用的文献

1
Clinical toxicity of sulfonamides.磺胺类药物的临床毒性
Ann N Y Acad Sci. 1957 Oct 12;69(3):417-47. doi: 10.1111/j.1749-6632.1957.tb49682.x.
2
Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations.某些磺胺类药物及磺胺类药物组合的有效血浆和尿液浓度。
Ann Med Exp Biol Fenn. 1970;48(1):38-48.
3
Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination.磺胺甲恶唑-甲氧苄啶组合的人体药代动力学。
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明(甲氧苄啶-磺胺甲恶唑):抗菌活性及临床疗效的最新综述
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.
4
Clinical pharmacokinetics of co-trimazine.复方磺胺甲恶唑的临床药代动力学。
Clin Pharmacokinet. 1986 Sep-Oct;11(5):372-86. doi: 10.2165/00003088-198611050-00003.
5
Trimethoprim/sulphonamide: concluding remarks.甲氧苄啶/磺胺类药物:总结发言。
Infection. 1979;7 Suppl 4:S417-8. doi: 10.1007/BF01639026.
Acta Med Scand. 1972 Dec;192(6):483-92. doi: 10.1111/j.0954-6820.1972.tb04852.x.
4
Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects.在健康人体受试者中进行的甲氧苄啶与不同剂量磺胺嘧啶的药代动力学研究。
Chemotherapy. 1973;19(5):289-98. doi: 10.1159/000221467.
5
A method for the rapid determination of the number of patients to include in a controlled clinical trial.一种用于快速确定纳入对照临床试验患者数量的方法。
Lancet. 1966 Dec 17;2(7477):1357-8. doi: 10.1016/s0140-6736(66)92098-8.
6
Bacteriostatic and bactericidal activity of two trimethoprim-sulfonamide combinations.两种甲氧苄啶-磺胺组合的抑菌和杀菌活性
Chemotherapy. 1976;22(3-4):262-73. doi: 10.1159/000221933.
7
[A new low-dosage trimethoprim-sulfonamide for long term treatment of chronic urinary tract infections].一种用于慢性尿路感染长期治疗的新型低剂量甲氧苄啶-磺胺甲恶唑
Ugeskr Laeger. 1976 Mar 15;138(12):735-7.
8
Kinetics of a sulfadiazine-trimethoprim combination.磺胺嘧啶-甲氧苄啶复方制剂的动力学
Clin Pharmacol Ther. 1977 Aug;22(2):211-24. doi: 10.1002/cpt1977222211.
9
Synergistic activity of co-trimazine and co-trimoxazole in the urine.复方甲氧苄啶和复方新诺明在尿液中的协同活性。
Infection. 1979;7 Suppl 4:S324-9. doi: 10.1007/BF01639008.
10
Antibacterial activity of co-trimazine in vitro and in vivo.复方磺胺甲恶唑的体内外抗菌活性。
Infection. 1979;7(2):74-80. doi: 10.1007/BF01641617.